Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines

prnasiaAugust 02, 2021

Tag: Biokangtai , PFDA , COVID-19 vaccine

PharmaSources Customer Service